Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHRM2102 > Week 2: Cardiovascular Risk > Flashcards

Week 2: Cardiovascular Risk Flashcards

1
Q

… is a progressive disease of the large arteries, caused by the local accumulation of lipids and fibrous elements together with inflammation.

A

Atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

T or F
Atherosclerosis is largely “silent” in patients, until a rupture of a plaque occurs, or the total blockage of an artery affects tissues in its vicinity.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T or F
The exact causes of atherosclerosis are not clear

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is atherosclerosis thought to start?

A

With damage to the endothelium of an artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does plaque form in an artery?

A
  1. Damage to the endothelium of an artery
  2. Cholesterol molecules get trapped and oxidise
  3. Monocytes from the blood stream navigate to the area
  4. Stimulation from the oxidised cholesterol turns monocytes into macrophages
  5. Macrophages eat and digest the cholesterol
  6. The macrophages change into foam cells
  7. Foam cells accumulate to form plaque.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T or F
plaque development cannot occur over years as adverse affects will arise well before then

A

F
plaque development can occur over years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

… cells cover the surface of inter-arterial plaque build up, creating a thick, fibrous cap.

A

smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Inter-arterial plaque can be … (there is a thick and fibrous cap covering the deposited lipid pool), or … (plaque that may rupture)

A

stabilised
vulnerable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name the three layers of the arteriole

A

tunica intima, tunica media, and tunica adventitia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T or F
Some people can have severe atherosclerosis with no symptoms

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LDL-C is good/bad cholesterol whilst HDL-C is good/bad cholesterol

A

bad
good

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T or F
Atherosclerosis is thought to be affected equally by both genetics and environment/lifestyle.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List some modifiable risk factors to developing atherosclerosis

A

Elevated LDL-C, reduced HDL-C, diabetes, cigarette smoking, obesity, physical inactivity and hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cholesterol can be obtained by the body via what two ways?

A

either a diet of animal tissues or synthesised endogenously by the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T or F
Cholesterol is needed for the absorption of lipid-soluble vitamins from the GI tract.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which lipoprotein has the most free cholesterol?

A

LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which type of lipoprotein is the largest?

A

Chylomicrons

18
Q

What function do high-density lipoproteins (HDL) perform in the body?

A

move surplus cholesterol back to the liver from tissues for storage or excretion

19
Q

Low-density lipoproteins (LDL) are what is formed after VLDL lipoproteins have had their … removed.

A

triglycerides

20
Q

Which type of lipoproteins are able to cross dysfunctional endothelium and contribute to foam cell formation?

A

LDLs

21
Q

… are responsible for the transport of lipids from the intestinal absorption after eating, taking its contents to the tissues and liver

A

Chylomicrons

22
Q

The right order of lipoproteins in terms of density from lowest to highest is…

A

chylomicrons – VLDL – IDL – LDL – HDL

23
Q

Lipoproteins are composed of; An outer shell of …, core of fats including … and surface … molecules to help tissues recognise and take up the particles.

A

phospholipids
cholesterols
apoproteins

24
Q

The surface of lipoproteins contains
hydrophilic/hydrophobic components while the core contains hydrophilic/hydrophobic components.

A

hydrophilic
hydrophobic

25
Q

T or F
One of the functions of apolipoproteins is to mediate binding of lipoproteins to lipoprotein receptors.

A

T

26
Q

Cholesterol and lipid from our food intake is absorbed from the … and transported in …

A

small intestine
chylomicrons

27
Q

List some secondary causes of dyslipidaemia

A

A sedentary lifestyle
High intake of saturated fat, cholesterol and trans fats.
Cigarette smoking
Anabolic steroids
Some medications

28
Q

Dyslipidaemia is usually primarily due to … causes

A

genetic

29
Q

The primary goal of drug therapy in dyslipidaemia is the reduction of …

A

LDL-C

30
Q

Match the pleiotropic effects to their corresponding benefits:

  1. Increased NO production
  2. Atherosclerotic plaque stabilisation
  3. Reduced platelet aggregability

a. Reduced likelihood of plaque rupture
b. Reduced risk of blood clot formation
c. Vasodilation

A

1c, 2a, 3b

31
Q

Match the pleiotropic effects to their corresponding benefits:

  1. Reduction in vascular formation
  2. Down-regulation of AT1 receptor expression
  3. Reduction in VSMC migration

a. Decreased rate of plaque build-up
b. Reduced cytokines and signaling molecules driving inflammation
c. Decreased effects on Ang-II

A

1b, 2c, 3a

32
Q

List some rare but serious concentration-dependent reactions to statin medications

A

Myopathy and rhabdomyolysis (breakdown of skeletal muscle sarcolemma, releasing muscle fibre contents (myoglobin) into the bloodstream, possibly leading to acute kidney injury).

33
Q

Name some drug classes that can be prescribed for the treatment of dyslipidaemia.

A

Statins, fibrates, ezetimibe, bile-acid binding resins (in severe disease), bempedoic acid, monoclonal antibodies to PCSK9 and siRNA treatment of PCSK9

34
Q

Bempedoic acid works by inhibiting … which is two steps upstream from …, which statins inhibit

A

adenosine triphosphate citrate lyase (ACL)
HMG-CoA reductase

35
Q

Match the drug class with its primary mechanism of action:

  1. Statins
  2. Fibrates
  3. Bempedoic acid
  4. Small interfering RNA coding for PCSK9

a. Inhibition of ACL
b. Inhibition of HMG-CoA reductase
c. Inhibits synthesis of PCKS9
d. Increasing expression of lipoprotein lipase

A

1b, 2d, 3a, 4c,

36
Q

What seven factors are used to estimate CVD risk?

A

Smoking, elevated blood pressure, dyslipidaemia, diabetes, increasing age, male sex and left ventricular hypertrophy.

37
Q

What is the mechanism of action for statins?

A

Reduce endogenous cholesterol by competitively antagonising HMG-CoA reductase -> Reduces melvalonate -> reducing cholesterol synthesis

38
Q

What is the rate limiting step in cholesterol biosynthesis?

A

The enzyme HMG-CoA reductase

39
Q

What is the mechanism of action for fibrates?

A

Agonise PPAR-alpha -> Transcription of LP lipase and major HDL lipoproteins -> Large decrease in circulating VLDL/triglycerides with a moderate decrease in LDL and increase in HDL

40
Q

What is the mechanism of action for ezetimibe?

A

Inhibits cholesterol absorption in the ileum, causing an increased need for cholesterol. In response tissues will increase their LDL receptor lvls which will lead to an increase in LDL excretion from the body via bile

41
Q

What is the mechanism of action for bempedoic acid?

A

Inhibits adenosine triphosphate citrate lyase (ACL), an enzyme two steps upstream of HMG-CoA reductase. By reducing the body’s ability to synthesise cholesterol, LDL-C in the bloodstream is more likely to be cleared due to an increased density of LDL receptors being expressed on tissues.

42
Q

What is the mechanism of action for monoclonal antibodies to PCK9?

A

PCSK9 is made by cells and plays a role in degrading LDL receptors. Blocking PCSK9 reduces the lysosomal degradation of LDL receptors. This mechanism thus increases the number of LDL receptors present.

PHRM2102 (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions